000724319 000__ 05301cam\a2200493Ii\4500
000724319 001__ 724319
000724319 005__ 20230306140527.0
000724319 006__ m\\\\\o\\d\\\\\\\\
000724319 007__ cr\cn\nnnunnun
000724319 008__ 141117t20142015sz\a\\\\o\\\\\001\0\eng\d
000724319 019__ $$a899275585$$a908083313
000724319 020__ $$a9783319103051$$qelectronic book
000724319 020__ $$a3319103059$$qelectronic book
000724319 020__ $$z9783319103044
000724319 035__ $$aSP(OCoLC)ocn895661063
000724319 035__ $$aSP(OCoLC)895661063$$z(OCoLC)899275585$$z(OCoLC)908083313
000724319 040__ $$aN$T$$beng$$erda$$epn$$cN$T$$dGW5XE$$dYDXCP$$dN$T$$dIDEBK$$dEBLCP
000724319 049__ $$aISEA
000724319 050_4 $$aRC280.U8
000724319 08204 $$a616.99/466059$$223
000724319 24500 $$aUterine myoma, myomectomy and minimally invasive treatments$$h[electronic resource] /$$cAndrea Tinelli, Antonio Malvasi, editors.
000724319 264_1 $$aCham :$$bSpringer,$$c[2014]
000724319 264_4 $$c©2015
000724319 300__ $$a1 online resource (xiii, 281 pages) :$$billustrations.
000724319 336__ $$atext$$btxt$$2rdacontent
000724319 337__ $$acomputer$$bc$$2rdamedia
000724319 338__ $$aonline resource$$bcr$$2rdacarrier
000724319 500__ $$aIncludes index.
000724319 5050_ $$aPreface; Contents; Contributors; 1: Pathophysiology of Uterine Myomas and Its Clinical Implications; Introduction; Prevalence and Histogenesis; Factors Influencing Growth of Leiomyomas; Estrogens (E); Progesterone (P); Growth Factors; Cytogenetics; High Mobility Group 1 Proteins; Uterine Inner and Outer Myometrium; Vascularization and Location of Uterine Myomas; Symptomatology of Uterine Myomas; Abnormal Uterine Bleeding; Infertility; Spontaneous Abortions; Pelvic Pain; Promising New Medical Therapeutic Agents; Progesterone Antagonists; Selective Progesterone Receptor Modulators (SPRMs)
000724319 5058_ $$aAsoprisnilProellex (CDB-4124); Ulipristal Acetate (CDB-2914); Aromatase Inhibitors (AIs); Summary and Conclusions; References; 2: Genetic and Genomics of Uterine Myomas; Introduction; Molecular Aspect of Uterine Leiomyomas; The Genomic Landscape of Uterine Myomas: Mutation Analysis and Chromosome Rearrangements; Epigenetics in Myomas; Pathways Influencing Disease; Perspectives; References; 3: Uterine Myomas and Histopathology; Introduction; Particular Types of Leiomyomata; STUMP; References; 4: Uterine Fibroids: Clinical Features; Introduction; Incidence; Risk Factors; Clinical Presentation
000724319 5058_ $$aNatural History of FibroidsDiagnosis; Treating Pre-operative Anemia; New Appearance of Fibroids; Uterine Changes Following Myomectomy; The Risk of Uterine Rupture After Myomectomy; References; 5: Uterine Myomas and Fertility; Introduction; Etiology, Pathophysiology and Genetic Origin; Etiology and Microscopy; Pathophysiology; Genetic Origin; Philosophy of Myomas in Infertility; Myomas and Fertility Outcome?; Implantation Rates; Recurrent Pregnancy Loss; Myomas During Pregnancy; Treatment Possibilities; Myomectomy and Fertility: Laparoscopic and Hysteroscopic Resection of Fibroids
000724319 5058_ $$aGeneral AspectsLaparoscopic Stepwise Enucleation of an Intramural Fibroid and Uterine Reconstruction; Hysteroscopic Myoma Enucleation Has to Be Performed According to the Depth of Infiltration into the Myometrium; Differentiation of Fibroids and Focal Endometriosis to Adenomatoid Tumors; Case 1; Case 2; Recurrence Rates; Fertility Outcome: Our Experience; Location of Myoma; Pregnancies and Deliveries; Mode of Delivery; Complications; Discussion and Conclusions; References; 6: Uterine Fibroid Pseudocapsule; Introduction; Anatomy of Fibroid Pseudocapsule
000724319 5058_ $$aNeurotransmitters in Myoma PseudocapsuleComparison Between Myoma Pseudocapsule and Prostate Capsule; Intracapsular Myomectomy; The Functional Autonomy of Pseudocapsule and Its Impact on Muscular Healing; The Advantage of Endoscopically Tailored Myomectomy and Prostatectomy; The Rationale of Intracapsular Myomectomy: Pro and Cons; Conclusions; References; 7: Adenomyosis and Adenomyomata; Introduction; Historical Background; Histological Definition; Etiology of Adenomyosis; Diagnostic Methods and the Uterine Junctional Zone; Symptomatology and Types of Adenomyosis
000724319 506__ $$aAccess limited to authorized users.
000724319 520__ $$aUterine myomas are the most common benign tumors in women, affecting the half of women and mostly in reproductive age. Myomas cause significant morbidity and are the single most common indication for hysterectomy around the world. Thus, myomas represent a major personal and public health concern worldwide. The diagnosis of fibroids can be established based on ultrasound and radiological imaging. Recent research on the genomics and molecular biology of myomas has enabled us to better understand the pathogenesis and pathophysiology of this benign tumor, but more remains to be discovered. In the.
000724319 588__ $$aOnline resource; title from PDF title page (SpringerLink, viewed December 29, 2014).
000724319 650_0 $$aMyometrium$$xTumors$$xSurgery.
000724319 7001_ $$aTinelli, Andrea,$$eeditor.
000724319 7001_ $$aMalvasi, Antonio,$$eeditor.
000724319 77608 $$iPrint version:$$aTinelli, Andrea$$tUterine Myoma, Myomectomy and Minimally Invasive Treatments$$dCham : Springer International Publishing,c2014$$z9783319103044
000724319 852__ $$bebk
000724319 85640 $$3SpringerLink$$uhttps://univsouthin.idm.oclc.org/login?url=http://link.springer.com/10.1007/978-3-319-10305-1$$zOnline Access$$91397441.1
000724319 909CO $$ooai:library.usi.edu:724319$$pGLOBAL_SET
000724319 980__ $$aEBOOK
000724319 980__ $$aBIB
000724319 982__ $$aEbook
000724319 983__ $$aOnline
000724319 994__ $$a92$$bISE